Dr. Block is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7500 Mercy Rd
Ste 1300
Omaha, NE 68124Phone+1 402-393-3110Fax+1 402-393-4499
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1980 - 1981
- Rush University Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1980
- Rush University Medical CenterResidency, Internal Medicine, 1976 - 1979
- Albany Medical CollegeClass of 1976
Certifications & Licensure
- IA State Medical License 1989 - 2026
- NE State Medical License 1989 - 2026
- WI State Medical License 1980 - 2025
- IL State Medical License 1977 - 1993
- PA State Medical License 1983 - 1990
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer Start of enrollment: 2012 Apr 01
- Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index Start of enrollment: 2013 Apr 01
- A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2014 Jul 22
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsPreservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when adde...Volkmar Mueller, Andrew M Wardley, Elisavet Paplomata, Erika Hamilton, Amelia Zelnak
European Journal of Cancer. 2021-06-29 - 18 citationsA phase II study of topical ceramides for cutaneous breast cancer.Aminah Jatoi, Vera J. Suman, Paul L. Schaefer, Margaret Block, Charles L. Loprinzi
Breast Cancer Research and Treatment. 2003-07-01 - 76 citationsRandomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuva...Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga, William Fraser Symmans, Ben Ho Park
Journal of Clinical Oncology. 2021-06-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: